Drugs for BNCT: BSH and BPA

Wolfgang A.G. Sauerwein; Pierre M. Bet; Andrea Wittig

doi:https://doi.org/10.1007/978-3-642-31334-9_8

Drugs for BNCT: BSH and BPA

Wolfgang A.G. Sauerwein, Pierre M. Bet, Andrea Wittig

Clinical pharmacology and pharmacy (VUmc)

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

17 Citations (Scopus)

Abstract

This chapter is based on a shortened version of the investigators brochures from the EORTC clinical trials 11001 and 11011 concerning the boron compounds sodium borocaptate (BSH) and boronophenylalanine (BPA). It summarizes essential information that might be asked by regulatory authorities. The intention of this chapter is to support and to facilitate the preparation of new clinical trials based on these compounds. However, this compilation cannot offer a complete and final description of all aspects concerning these 2 compounds necessary to file for drug approval.

Original language	English
Title of host publication	Neutron Capture Therapy
Subtitle of host publication	Principles and Applications
Publisher	Springer-Verlag Berlin Heidelberg
Pages	117-160
Number of pages	44
Volume	9783642313349
ISBN (Electronic)	9783642313349
ISBN (Print)	3642313337, 9783642313332
DOIs	https://doi.org/10.1007/978-3-642-31334-9_8
Publication status	Published - 1 Aug 2012

Access to Document

https://doi.org/10.1007/978-3-642-31334-9_8

Cite this

@inbook{b207cd3e523c447799dffb1dce4cfbbf,

title = "Drugs for BNCT: BSH and BPA",

abstract = "This chapter is based on a shortened version of the investigators brochures from the EORTC clinical trials 11001 and 11011 concerning the boron compounds sodium borocaptate (BSH) and boronophenylalanine (BPA). It summarizes essential information that might be asked by regulatory authorities. The intention of this chapter is to support and to facilitate the preparation of new clinical trials based on these compounds. However, this compilation cannot offer a complete and final description of all aspects concerning these 2 compounds necessary to file for drug approval.",

author = "Sauerwein, {Wolfgang A.G.} and Bet, {Pierre M.} and Andrea Wittig",

year = "2012",

month = aug,

day = "1",

doi = "https://doi.org/10.1007/978-3-642-31334-9_8",

language = "English",

isbn = "3642313337",

volume = "9783642313349",

pages = "117--160",

booktitle = "Neutron Capture Therapy",

publisher = "Springer-Verlag Berlin Heidelberg",

}

TY - CHAP

T1 - Drugs for BNCT

T2 - BSH and BPA

AU - Sauerwein, Wolfgang A.G.

AU - Bet, Pierre M.

AU - Wittig, Andrea

PY - 2012/8/1

Y1 - 2012/8/1

N2 - This chapter is based on a shortened version of the investigators brochures from the EORTC clinical trials 11001 and 11011 concerning the boron compounds sodium borocaptate (BSH) and boronophenylalanine (BPA). It summarizes essential information that might be asked by regulatory authorities. The intention of this chapter is to support and to facilitate the preparation of new clinical trials based on these compounds. However, this compilation cannot offer a complete and final description of all aspects concerning these 2 compounds necessary to file for drug approval.

AB - This chapter is based on a shortened version of the investigators brochures from the EORTC clinical trials 11001 and 11011 concerning the boron compounds sodium borocaptate (BSH) and boronophenylalanine (BPA). It summarizes essential information that might be asked by regulatory authorities. The intention of this chapter is to support and to facilitate the preparation of new clinical trials based on these compounds. However, this compilation cannot offer a complete and final description of all aspects concerning these 2 compounds necessary to file for drug approval.

UR - http://www.scopus.com/inward/record.url?scp=84949177564&partnerID=8YFLogxK

U2 - https://doi.org/10.1007/978-3-642-31334-9_8

DO - https://doi.org/10.1007/978-3-642-31334-9_8

M3 - Chapter

SN - 3642313337

SN - 9783642313332

VL - 9783642313349

SP - 117

EP - 160

BT - Neutron Capture Therapy

PB - Springer-Verlag Berlin Heidelberg

ER -

Drugs for BNCT: BSH and BPA

Abstract

Access to Document

Other files and links

Cite this